TEVA PHARMACEUTICAL INDUSTRIES LTD
President and Chief Executive Officer
In 2017, Kåre Schultz earned a total compensation of $17,027,741 as President and Chief Executive Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD.
Schultz received $14,229,808 in stock awards, which accounts for 83.57% of total compensation.
Schultz also received $2,000,009 in option awards, $333,333 in salary and $464,591 in other compensation.